Research & Development Market Research Reports & Industry Analysis
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Research & Development Industry Research & Market Reports
-
Medical & Recreational Marijuana Stores in the US - Industry Market Research Report
... years. The legalization of marijuana for medical and/or recreational purposes and the growing acceptance of legal marijuana use provided operators and investors with unprecedented opportunities. There has been no shortage of demand over recent years, ... Read More
-
Cannabis Equipment & Accessory Stores in the US - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
2025 Global: Hemp Source Cbd Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
Scientific Research & Development in the US - Industry Market Research Report
... government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over the past five years. While the COVID-19 pandemic provided increased government funding ... Read More
-
Critical Guidance on the Impact of AI Adoption on Life Science Investment Strategy: Bio-IT 2025
... key observations and industry implications resulting from the Bio-IT World Conference & Expo 2025, and the associated Cambridge Venture, Innovation, & Partnering (VIP) forum, on the impact of AI adoption on life science investment strategy. Read More
-
2025 Global: Hemp-Derived Cannabidiol Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
2025 Global: Gas Chromatography Based Cannabis Analysis Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Global Cannabidiol (CBD) Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Pharmaceutical Sterility Testing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Cannabis Products Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Canada Legal Cannabis Market Size, Share, And Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End-use (Medical, Recreational, Industrial), And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high ... Read More
-
Cannabis Vaporizers Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Life Science Analytics
... at a CAGR of 13.3% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the end of the ... Read More
-
Carglumic Acid
... CAGR of 5.3% over the analysis period 2024-2030. Orally Disintegrating Tablets, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$105.6 Million by the end of the ... Read More
-
Acne Drugs
... CAGR of 6.9% over the analysis period 2024-2030. Inflammatory, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.6 Billion by the end of the analysis period. ... Read More
-
Cannabis Beverages
... CAGR of 16.3% over the analysis period 2024-2030. Non-Alcoholic Beverage, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Cannabis Extract
... CAGR of 15.6% over the analysis period 2024-2030. Oils, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$34.1 Billion by the end of the analysis period. ... Read More
-
Cannabidiol
... 14.5% over the analysis period 2024-2030. Hemp, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$14.3 Billion by the end of the analysis period. Growth in ... Read More
-
CBD Gummies
... CAGR of 28.8% over the analysis period 2024-2030. Low, one of the segments analyzed in the report, is expected to record a 28.2% CAGR and reach US$32.4 Billion by the end of the analysis period. ... Read More
-
In Vivo Contract Research Organization (CRO)
... reach US$8.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Pharmaceutical Contract Manufacturing
... at a CAGR of 5.2% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$93.8 Billion by the end of the ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
e-Clinical Trial Technologies
... at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$9.9 Billion by ... Read More
Research Assistance
